Literature DB >> 22614566

Mycobacterial tuberculosis superimposed on a Warthin tumor.

Kang-Chao Wu1, Bo-Nien Chen.   

Abstract

The concomitant occurrence of tuberculosis infection within a Warthin tumor is extremely rare, as only 6 cases have been previously reported in the English-language literature. We report a new case in a 92-year-old man, who presented with a 20-year history of a painless swelling in the right infra-auricular area that had recently become painful and larger. The patient had no history of tuberculosis, weight loss, or chronic cough. The fluctuant mass was aspirated, but histopathology and routine culture were negative. Computed tomography identified a 5-cm, heterogeneous, enhancing mass with multiple, variably sized, low-density areas without surrounding edema in the area of the right parotid gland. Complete excision was performed to relieve the patient's symptoms. Histopathology diagnosed an acid-fast bacillus infection within a Warthin tumor. On polymerase chain reaction testing, formalin-fixed, paraffin-embedded tissue was negative for tuberculosis, but subsequent culture identified Mycobacterium tuberculosis. Initially, the patient refused antituberculosis therapy, but he relented when miliary pulmonary tuberculosis was diagnosed 11 weeks postoperatively.

Entities:  

Mesh:

Year:  2012        PMID: 22614566     DOI: 10.1177/014556131209100514

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  2 in total

1.  Mycobacterium Tuberculosis Infection within a Warthin Tumor: A Case Report and Literature Review.

Authors:  Murat Ulusan; Yasin Abul; Sule Bakır
Journal:  N Am J Med Sci       Date:  2013-10

Review 2.  Warthin's tumor with necrotizing tuberculous granulomatous inflammation causing severe facial nerve adhesion in parotid gland: A case report and literature review.

Authors:  Shih-Lung Chen; Cheng-Cheng Hwang; Yu-Chih Liu; Wei-Ting Chen; Shih-Wei Yang
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.